Variant report
Variant | esv3322799 |
---|---|
Chromosome Location | chr20:22829252-22834150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543468386 | chr20:22829275-22829276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563425754 | chr20:22829312-22829313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150109492 | chr20:22829316-22829317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573004041 | chr20:22829326-22829327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113128728 | chr20:22829343-22829344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs202153133 | chr20:22829369-22829370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113492146 | chr20:22829411-22829412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138520203 | chr20:22829421-22829422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547643860 | chr20:22829458-22829459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570673205 | chr20:22829467-22829468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527387163 | chr20:22829469-22829470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199548681 | chr20:22829489-22829490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs57737024 | chr20:22829491-22829492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531801433 | chr20:22829492-22829493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556225086 | chr20:22829545-22829546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569765862 | chr20:22829566-22829567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535587035 | chr20:22829568-22829569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565957166 | chr20:22829576-22829577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191319842 | chr20:22829589-22829590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374407244 | chr20:22829598-22829599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368332773 | chr20:22829631-22829632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558395281 | chr20:22829670-22829671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183007096 | chr20:22829681-22829682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149277059 | chr20:22829690-22829691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543389153 | chr20:22829700-22829701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563387555 | chr20:22829746-22829747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573785398 | chr20:22829769-22829770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73900757 | chr20:22829776-22829777 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs77039609 | chr20:22829779-22829780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143531510 | chr20:22829793-22829794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148036350 | chr20:22829794-22829795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564387548 | chr20:22829805-22829806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142619064 | chr20:22829862-22829863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35522010 | chr20:22829914-22829915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549794039 | chr20:22829990-22829991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73620326 | chr20:22830086-22830087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187705745 | chr20:22830118-22830119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146044745 | chr20:22830137-22830138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549072458 | chr20:22830203-22830204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73900758 | chr20:22830258-22830259 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs535202988 | chr20:22830266-22830267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569627147 | chr20:22830284-22830285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs578193747 | chr20:22830425-22830426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536594870 | chr20:22830442-22830443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537386865 | chr20:22830450-22830451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557238284 | chr20:22830462-22830463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573649267 | chr20:22830476-22830477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140019485 | chr20:22830529-22830530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559783807 | chr20:22830530-22830531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371907708 | chr20:22830567-22830568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 20164919 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:22822000-22831600 | Weak transcription | A549 | lung |
2 | chr20:22830400-22831000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr20:22831200-22831600 | Weak transcription | Stomach Mucosa | stomach |
4 | chr20:22831600-22831800 | ZNF genes & repeats | A549 | lung |
5 | chr20:22831800-22832000 | Weak transcription | A549 | lung |
6 | chr20:22832000-22832600 | Enhancers | A549 | lung |
7 | chr20:22832200-22832600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr20:22832200-22832600 | Enhancers | HUVEC | blood vessel |
9 | chr20:22832200-22833000 | Enhancers | Stomach Mucosa | stomach |